from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1593c/-

LFCtreatmentdescriptionclass of inhibitor

-0.479

Amikacinug/mL Amikacintranslation

-0.274

Cap5-10ug/mL Capreomycintranslation

-0.306

Rox10-50 ug/mL Roxithromycintranslation

0.526

SM2-5 ug/mL Streptomycintranslation

0.243

Tet5-10 ug/mL Tetracyclinetranslation

-0.640

Rif0.2-5ug/mL Rifampicintranscription

0.209

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.977

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.346

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.706

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.130

Clofazimine10-13 ug/mL Clofaziminerespiration

0.110

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.749

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.514

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.418

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.214

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.407

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.088

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.167

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.210

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.865

KCN5-20 ug/mL Potassium cyaniderespiration

0.193

NaN30.2-2 mM Sodium aziderespiration

-2.280

Nigericin50 uM Nigericinrespiration

-0.002

TRC10-150 ug/mL Triclosanrespiration

-0.630

TRZ10-25 ug/mL Thioridazinerespiration

2.074

Valinomycin0.5-10 uM Valinomycinrespiration

-1.280

ZnSO42 mM ZnSO4respiration

-0.323

menadione6-10 ug/mL Menadionerespiration

-0.653

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.181

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.067

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.272

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.731

NRP_1Non-replicating persistence stage 1dosRassociated

-0.540

Amp0.2mg/mL AmpicillincellWall

0.220

Cephalexin20-100 ug/mL CephalexincellWall

-0.479

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.477

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-1.505

EMB10-20 ug/mL EthambutolcellWall

0.237

Eta12-40 ug/mL EthionamidecellWall

-0.223

INH0.2-0.4 ug/mL IsoniazidcellWall

0.027

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.186

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.002

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.731

BZA0.12 mg/mL BenzamidearomaticAmides

0.829

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.800

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.895

H2O24 mM hydrogen peroxideDNAdamaging

0.264

Levo10 ug/mL LevofloxacinDNAdamaging

-0.662

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.779

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.495

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.813

UVUV-irradiationDNAdamaging

-0.622

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.405

Antimycin12.5-50 ug/mL Antimycin A?

-0.147

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.144

PA_110-50 ug/mL Antitubercular compound PA-1?

0.050

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.045

PA8240.2-2 ug/mL PA-824?

1.298

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.118

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.037

Verapamil50 uM Verapamil?

-0.327

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.083

methoxatin10-20 ug/mL Methoxatin?